Form 424B2 - Prospectus [Rule 424(b)(2)]:
SEC Accession No. 0001140361-25-040063
Filing Date
2025-11-03
Accepted
2025-11-03 06:02:26
Documents
5

Document Format Files

Seq Description Document Type Size
1 424B2 ny20057651x1_424b2.htm 424B2 918824
2 logo_bms4.jpg GRAPHIC 43420
3 logo_bms6.jpg GRAPHIC 24461
4 logo_bms6x1.jpg GRAPHIC 54748
5 ny20057651x1_linechart01.jpg GRAPHIC 83150
  Complete submission text file 0001140361-25-040063.txt   1203503
Mailing Address ROUTE 206 AND PROVINCE LINE ROAD PRINCETON NJ 08543
Business Address ROUTE 206 AND PROVINCE LINE ROAD PRINCETON NJ 08543 6092524621
BRISTOL MYERS SQUIBB CO (Filer) CIK: 0000014272 (see all company filings)

EIN.: 220790350 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B2 | Act: 33 | File No.: 333-283810 | Film No.: 251441953
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address BLANCHARDSTOWN CORPORATE PARK 2 PLAZA 254 BLANCHARDSTOWN DUBLIN Ireland D15 T867
Business Address BLANCHARDSTOWN CORPORATE PARK 2 PLAZA 254 BLANCHARDSTOWN DUBLIN Ireland D15 T867 732-710-1396
BMS Ireland Capital Funding Designated Activity Co (Filer) CIK: 0002090756 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231